All News about Urogen Pharma Ltd
![](https://mms.businesswire.com/media/20240124917135/en/2007737/5/UroGen_logo2_%28R%29_%28002%29.jpg)
UroGen Initiates Submission of a Rolling NDA to the FDA for UGN-102
January 24, 2024
From UroGen Pharma Ltd.
Via Business Wire
![](https://mms.businesswire.com/media/20240117582883/en/2000536/5/UroGen_logo2_%28R%29_%28002%29.jpg)
![](https://mms.businesswire.com/media/20240111451437/en/1995580/5/UroGen_logo2_%28R%29.jpg)
UroGen Pharma to Participate in the B. Riley Healthcare Conference
January 11, 2024
From UroGen Pharma Ltd.
Via Business Wire
![](https://mms.businesswire.com/media/20231208128226/en/1964514/5/UroGen_logo2_%28R%29.jpg)
From UroGen Pharma Ltd.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Recap: UroGen Pharma Q3 Earnings
November 14, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Preview: UroGen Pharma's Earnings
November 13, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for UroGen Pharma
October 04, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/israel-hama-war-shutter3_5.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20231114806402/en/1943601/5/UroGen_logo2_%28R%29.jpg)
UroGen Pharma Reports Third Quarter 2023 Financial Results
November 14, 2023
From UroGen Pharma Ltd.
Via Business Wire
![](https://mms.businesswire.com/media/20231113669672/en/1942473/5/UroGen_logo2_%28R%29_%28002%29.jpg)
![](https://mms.businesswire.com/media/20231107012900/en/1936534/5/UroGen_logo2_%28R%29.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Where UroGen Pharma Stands With Analysts
July 31, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/israel_war_shutter2.jpeg?width=1200&height=800&fit=crop)
Cathie Wood's ARK Israel Innovative Tech ETF Braces For Impact Amid Regional Warfare: 10 Stocks To Watch
October 09, 2023
Via Benzinga
Topics
ETFs
![](https://mms.businesswire.com/media/20231003915532/en/1904990/5/UroGen_logo2_%28R%29_%28002%29.jpg)
![](https://ml.globenewswire.com/media/5e2f90ec-c9a5-4fcd-99c8-2c8c838ac033/small/eledon-logo-1230-png.png)
![](https://mms.businesswire.com/media/20230908931196/en/1884516/5/UroGen_logo2_%28R%29.jpg)
From UroGen Pharma Ltd.
Via Business Wire
![](https://mms.businesswire.com/media/20230831174677/en/1878418/5/UroGen_logo2_%28R%29.jpg)
UroGen Pharma to Present at Upcoming Investor Conferences
August 31, 2023
From UroGen Pharma Ltd.
Via Business Wire
![](https://mms.businesswire.com/media/20230810124339/en/1863979/5/UroGen_logo2_%28R%29.jpg)
![](https://mms.businesswire.com/media/20230808428206/en/1861346/5/UroGen_logo2_%28R%29_%28002%29.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/08/17/image15.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230802943779/en/1858084/5/UroGen_logo2_%28R%29.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://media.bespokepremium.com/uploads/2023/08/r3k.png)
![](https://mms.businesswire.com/media/20230731957828/en/1853701/5/UroGen_logo2_%28R%29.jpg)
![](https://g.foolcdn.com/editorial/images/741739/healthcare-lab-treatment-research-scientist-1.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/07/28/benzinga_stock_whisper_index.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/28/enphase_energy_-_logo.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.